FATE THERAPEUTICS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Adawi Kamal | Chief Financial Officer | Award / Grant | 75,000 | — | — | 75,000 | Oct 20, 2025 |
| TAHL CINDY | See Remarks | Sale | 9,037 | $1.06 | $9,579 | 397,670 | Aug 4, 2025 |
| Valamehr Bahram | President and CEO | Sale | 14,466 | $1.06 | $15,334 | 334,898 | Aug 4, 2025 |
| TAHL CINDY | See Remarks | Award / Grant | 70,000 | — | — | 406,707 | Jan 15, 2025 |
| Bressi Jerome Charles | See Remarks | Award / Grant | 65,000 | — | — | 335,203 | Jan 15, 2025 |
| Bressi Jerome Charles | See Remarks | Sale | 5,980 | $1.55 | $9,269 | 270,203 | Jan 10, 2025 |
| TAHL CINDY | See Remarks | Sale | 5,654 | $1.55 | $8,764 | 336,707 | Jan 10, 2025 |
| Valamehr Bahram | President and CEO | Sale | 8,705 | $1.54 | $13,406 | 349,364 | Jan 10, 2025 |
| Green Jeremy | — | Purchase | 397,964 | $1.68 | $668,580 | 12,884,277 | Dec 20, 2024 |
| Green Jeremy | — | C | 30,110 | — | — | 12,827,946 | Dec 12, 2024 |
| Xu Yuan | — | Sale | 633 | $4.23 | $2,678 | 8,669 | Aug 6, 2024 |
| Valamehr Bahram | Chief R&D Officer | Award / Grant | 200,000 | — | — | 358,069 | Jul 29, 2024 |
| TAHL CINDY | General Counsel and Secretary | Award / Grant | 200,000 | — | — | 342,361 | Jul 29, 2024 |
| Dulac Edward J III | Chief Financial Officer | Sale | 2,447 | $7.77 | $19,013 | 101,479 | Mar 4, 2024 |
| Dulac Edward J III | Chief Financial Officer | Sale | 1,849 | $5.00 | $9,245 | 103,926 | Jan 29, 2024 |
| TAHL CINDY | General Counsel and Secretary | Sale | 10,874 | $4.37 | $47,519 | 142,361 | Jan 9, 2024 |
| Valamehr Bahram | Chief R&D Officer | Sale | 11,271 | $4.38 | $49,367 | 158,069 | Jan 9, 2024 |
| Wolchko J Scott | President and CEO | Sale | 14,391 | $4.37 | $62,889 | 371,248 | Jan 9, 2024 |
| Dulac Edward J III | Chief Financial Officer | Sale | 7,028 | $4.37 | $30,712 | 105,775 | Jan 9, 2024 |
| Dulac Edward J III | Chief Financial Officer | Sale | 5,182 | $3.66 | $18,966 | 112,803 | Jan 2, 2024 |
| Redmile Group, LLC | — | Other | 1,655,370 | $3.72 | $6,157,976 | 13,135,758 | Dec 26, 2023 |
| Dulac Edward J III | Chief Financial Officer | Sale | 1,585 | $3.50 | $5,548 | 117,985 | Dec 18, 2023 |
| TAHL CINDY | General Counsel and Secretary | Sale | 24,363 | $2.40 | $58,471 | 153,235 | Nov 9, 2023 |
| Dulac Edward J III | Chief Financial Officer | Sale | 4,718 | $2.80 | $13,210 | 119,570 | Aug 18, 2023 |
| Xu Yuan | — | Sale | 632 | $3.71 | $2,345 | 9,302 | Aug 4, 2023 |
| Powl Brian T. | Chief Commercial Officer | Sale | 3,854 | $4.87 | $18,769 | 41,146 | Jul 5, 2023 |
| Dulac Edward J III | Chief Financial Officer | Sale | 5,182 | $4.83 | $25,029 | 124,288 | Jul 5, 2023 |
| Xu Yuan | — | Sale | 3,460 | $5.58 | $19,307 | 9,934 | Jun 14, 2023 |
| Green Jeremy | — | Purchase | 20,000 | $5.99 | $119,800 | 12,879,119 | Apr 21, 2023 |
| Chu Yu-Waye | Chief Medical Officer | Sale | 2,317 | $6.58 | $15,246 | 140,676 | Apr 18, 2023 |
| Green Jeremy | — | C | 167,205 | — | — | 13,135,758 | Apr 14, 2023 |
| MENDLEIN JOHN | — | Option Exercise | 28,461 | $1.37 | $38,992 | 311,231 | Jan 19, 2023 |
| MENDLEIN JOHN | — | Purchase | 88,048 | $5.67 | $499,232 | 246,139 | Jan 13, 2023 |
| Valamehr Bahram | Chief R&D Officer | Option Exercise | 423 | $1.37 | $580 | 169,340 | Jan 12, 2023 |
| Wolchko J Scott | President and CEO | Sale | 45,907 | $5.24 | $240,553 | 385,639 | Jan 10, 2023 |
| Valamehr Bahram | Chief R&D Officer | Sale | 10,917 | $5.24 | $57,205 | 168,917 | Jan 10, 2023 |
| TAHL CINDY | General Counsel and Secretary | Sale | 11,553 | $5.24 | $60,538 | 177,598 | Jan 10, 2023 |
| Plavsic Mark | Chief Technical Officer | Sale | 3,418 | $5.24 | $17,910 | 123,705 | Jan 10, 2023 |
| Dulac Edward J III | Chief Financial Officer | Sale | 7,331 | $5.24 | $38,414 | 129,470 | Jan 10, 2023 |
| Chu Yu-Waye | Chief Medical Officer | Sale | 7,825 | $5.24 | $41,003 | 143,208 | Jan 10, 2023 |
| Dulac Edward J III | Chief Financial Officer | Sale | 4,703 | $29.75 | $139,914 | 137,233 | Aug 18, 2022 |
| Wolchko J Scott | President and CEO | Option Exercise | 6,246 | $2.70 | $16,864 | 437,792 | Jul 22, 2022 |
| Valamehr Bahram | Chief R&D Officer | Option Exercise | 17,158 | $2.73 | $46,841 | 196,992 | Jul 7, 2022 |
| Valamehr Bahram | Chief R&D Officer | Option Exercise | 5,842 | $2.73 | $15,949 | 187,676 | Jul 6, 2022 |
| Plavsic Mark | Chief Technical Officer | Sale | 3,719 | $24.61 | $91,525 | 127,123 | Jul 5, 2022 |
| Powl Brian T. | Chief Commercial Officer | Award / Grant | 45,000 | — | — | 45,000 | Jun 27, 2022 |
| Redmile Group, LLC | — | Award / Grant | 8,650 | — | — | 12,968,553 | Jun 9, 2022 |
| Lee Michael Stewart | — | Award / Grant | 8,650 | — | — | 11,331 | Jun 9, 2022 |
| Xu Yuan | — | Award / Grant | 8,650 | — | — | 13,394 | Jun 9, 2022 |
| RASTETTER WILLIAM H | — | Award / Grant | 8,650 | — | — | 11,331 | Jun 9, 2022 |